Expectations of limited growth and poor performance, along with shrinking revenue, contribute to the company's low P/S ratio. Shareholders accept this, anticipating no pleasant surprises in future revenue. If recent trends persist, share price is unlikely to see significant movement soon.
Wanbangde Pharmaceutical Holding Group Stock Forum
No comment yet